Case Cluster of RT-PCR COVID-19 Positive Patients with an Unexpected Benign Clinical Course With Vitamin D, Melatonin, Vitamin C, and Viscum Album
11 Pages Posted: 9 Feb 2021
Date Written: February 4, 2021
Background: The SARS-COV-2 global pandemic has been noted to have a differential effect on those exposed depending on risk factors such as age, diabetes, cardiovascular disease and cancer.
Case presentation: We report a case series of 12 confirmed positive patients and 12 presumptive positive patients all of whom had either an entirely asymptomatic or relatively mild clinical course. 2 patients had active cancer, 3 patients were cancer survivors, 1 patient without cancer was 74 years old. All patients were treated early in their disease course with vitamin D loading (50,000iu daily for 3 days), 60 to 240mg melatonin, and 2000mg oral vitamin C. The 6 high risk patients and one 59 year old patient were treated with at least 2 intravenous doses of vitamin C. The 2 patients with active cancer received 75 grams of vitamin C (one daily, the other every other day). All of the high risk patients had a nearly asymptomatic clinical course and were tested after 10 days and all had a RT PCR for COVID-19 that was negative. The 17 remaining patients also had a relatively benign course though 4 patients (2 in their 20s, 2 in their 50s) received this treatment course later in the course of their illness, these were notably the only patients who had more than a mild sore throat or low grade fever.
Conclusion: We report these unexpectedly positive clinical outcomes of COVID-19 patients including patients with different risk factors, under supplemental vitamin C and D and melatonin. These supplements have a favorable safety profile and are already being suggested as potentially disease altering therapies in the ongoing COVID-19 pandemic.
Note: Funding: No funding was received for the elaboration of this case report.
Declaration of Interests: Dr Hancock owns and operates Humanizing Medicine LLC, an integrative medical clinic that provides intravenous vitamin C and mistletoe as a substantial part of its revenue. Less than 0.5% of yearly revenue is obtained from selling high dose melatonin. Vitamin D is not sold at his clinic. No other conflict of interest are declared.
Ethics Approval Statement: Informed consent was obtained from all patients or their guardians before publishing any of their details in this report. Patients were given the opportunity to review the published version of this report.
Keywords: COVID-19, Cancer, Vitamin D, Melatonin, Vitamin C
Suggested Citation: Suggested Citation